Evidence-Based Diabetes Management > March 2018
Evidence-Based Diabetes Management - March 2018
Evidence-Based Diabetes Management
The Potential of a Population Health Strategy to Improve Healthcare Outcomes and Reduce Costs for Medicaid Programs
March 30, 2018 – David J. Dzielak, PhD
With Medicaid consuming a larger share of the Mississippi's budget, innovative solutions were needed to deliver improved health outcomes at a lower cost. A public-private partnership was created to pursued a population health strategy aimed at reducing preterm births and preventing the progression of prediabetes to type 2 diabetes.
March 31, 2018 – Dan Sheeran
Missed sessions are the obvious place where digital programs can find a place in the launch of Medicare's first fully reimbursed preventive service.
March 31, 2018 – Henry Anhalt, DO
Science 37 hopes to help researchers produce clinical trial results that are closer to real-world experiences, for the benefit of patients, pharma, and payers.
March 31, 2018 – Ashby F. Walker, PhD; Jaclyn M. Hall, PhD; Elizabeth A. Shenkman, PhD; Matthew J. Gurka, PhD; Heather L. Morris, PhD; Michael J. Haller, MD; Henry J. Rohrs, MD; Kelsey R. Salazar, MPH; and Desmond A. Schatz, MD
Enrollment, claims, and spatial data are used to demonstrate the importance of outreach strategies for families in rural areas who have children with diabetes. Spatial barriers, alone, do not fully elucidate racial/ethnic disparities in pediatric diabetes for street-level location. (For Tables and the Figure, please access the PDF on the last page.)
March 31, 2018 – Nadia J. Aneese, PharmD; Alexandra Halalau, MD; Sarah Muench, PharmD; Daniel Shelden, DO; Janna Fett, PharmD; Colleen Lauster, PharmD
This study evaluated a pharmacist-managed diabetes clinic to determine its impact on diabetes-related quality measures.(For Tables and Figures, please access the PDF on last page.)
March 31, 2018 – Robert A. Gabbay, MD, PhD, FACP
A commentary from our editor-in-chief on the recent guidance from the American College of Physicians regarding glycemic control for adults with type 2 diabetes.